Trump Invites Elon Musk Tim Cook Larry Fink and Other Top CEOs to Join China Trip for Xi Summit BofA Expects New Gemini Model Launch at Google IO Amid AI Race Intensification Telos Corporation TLS Reports Strong Q1 2026 Revenue NA EPS Beats Alamo Group ALG Q1 2026 Earnings EPS 241 Beats Estimates Nvidia Shares Dip After Earnings Why Sellers Might Be Overlooking the Bigger Picture Ebola Outbreak Prompts Isolation for DR Congo World Cup Squad Potential Travel and Economic Disruptions Kevin Warsh to Be Sworn in as Federal Reserve Chair on Friday Nvidia Revenue Surges 85 as AI Boom Continues Shares Dip on Caution Offer for Sale OFS Explained A Guide to How It Works on Stock Exchanges Traders Speculate on IonQ Micron and Anduril as Next Potential US Government Equity Stakes Consolidated Water Co Q1 2026 Earnings EPS Falls Short of Consensus on Operational Headwinds VLO Q1 2026 Earnings Strong EPS Beat Drives Stock Higher TG Therapeutics Q1 2026 Earnings EPS Disappoints as Stock Declines FMC Q1 2026 Earnings EPS Surpasses Estimates with NarrowerThanExpected Loss Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings Wider Than Expected Loss Highlights PreRevenue Challenges BDX Q1 2026 Earnings EPS Surpasses Estimates with 347 Beat Red Rock Resorts RRR Holds Steady With Modest Gains as Key Levels Remain in Focus Editas Medicine Surges 1591 Gene Editing Stock Breaks Above Key Support ACNB Corporation ACNB Faces Mild Pullback Approaches Key Support at 5168 Enlivex Ltd ENLV Rallies 14 Key Levels and Technical Outlook Calamos Global Total Return Fund CGO Gains Ground as Price Approaches Key Resistance Endurance Technologies IPO Opens for Subscription Auto Component Maker Targets Rs 1162 Crore Memory Chip Supercycle 2026 Micron and SanDisk Positioned for AIDriven Demand Surge Oura Health Files Confidentially for IPO Signaling Move Toward Public Markets EU Parliament Approves US Tariff Deal Implementation Amid Ongoing Trade Tensions UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister European Commission Fines Temu 200 Million Over Illegal and Dangerous Product Sales Kazia Therapeutics Q1 2026 Earnings A WiderThanExpected Loss Yet Shares Gain Ground KALA Bio Dips 65 Support Test Looms as Biotech Faces Pressure